UK On Cusp Of Integrated Care And New Regulatory Fees But Innovation Adoption Pressures Remain
UK patients see benefits of AI but medtech industry must take heed of changes ushered in by new Health and Care Act
New medtech regulatory policy, technology adoption challenges and NHS architecture changes under the new Health and Care Act will give system UK users much to ponder over this summer.
You may also be interested in...
NHS England is canvassing views on its plan to establish the NHS Payment System, to replace the current national tariff payment system, from April 2023.
The spotlight is on IVDs in the post-COVID phase. Innovators in university spin-outs and the established industry have responded with new technologies, creating a vibrant scene. Regulators and reimbursors must not disrupt the momentum, say BIVDA’s regulatory affairs manager Ashleigh Batchen and chief executive Doris-Ann Williams.
Inaugural artificial intelligence recommendations from NICE on radiotherapy contouring should allow clinicians to spend more time with patients and on complex cases where AI is not an option. But large language models are not appropriate in all cases, cautions Adrian Sutherland, principal healthcare architect at Endava consultancy.